electroCore, Inc./$ECOR
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About electroCore, Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
Ticker
$ECOR
Sector
Primary listing
Industry
Health Care Equipment & Supplies
Headquarters
Employees
73
ISIN
US28531P2020
Website
ECOR Metrics
BasicAdvanced
$40M
-
-$1.55
0.80
-
Price and volume
Market cap
$40M
Beta
0.8
52-week high
$16.78
52-week low
$4.47
Average daily volume
76K
Financial strength
Current ratio
1.524
Quick ratio
1.173
Long term debt to equity
87.514
Total debt to equity
95.853
Profitability
EBITDA (TTM)
-11.426
Gross margin (TTM)
85.22%
Net profit margin (TTM)
-46.24%
Operating margin (TTM)
-45.87%
Effective tax rate (TTM)
0.16%
Revenue per employee (TTM)
$360,000
Management effectiveness
Return on assets (TTM)
-50.68%
Return on equity (TTM)
-276.15%
Valuation
Price to revenue (TTM)
1.599
Price to book
9.1
Price to tangible book (TTM)
9.1
Price to free cash flow (TTM)
-4.818
Free cash flow yield (TTM)
-20.76%
Free cash flow per share (TTM)
-111.15%
Growth
Revenue change (TTM)
41.54%
Earnings per share change (TTM)
-43.74%
3-year revenue growth (CAGR)
62.68%
3-year earnings per share growth (CAGR)
-27.32%
ECOR News
AllArticlesVideos
electroCore Announces First Quarter 2025 Financial Results
GlobeNewsWire·2 months ago
electroCore Completes Acquisition of NeuroMetrix, Gaining Access to its Quell Platform, Creating Significant Player in Non-Invasive Bioelectronic Technologies
GlobeNewsWire·2 months ago
electroCore's Truvaga™ Now Works with the Apple Health app
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for electroCore, Inc. stock?
electroCore, Inc. (ECOR) has a market cap of $40M as of July 03, 2025.
What is the P/E ratio for electroCore, Inc. stock?
The price to earnings (P/E) ratio for electroCore, Inc. (ECOR) stock is 0 as of July 03, 2025.
Does electroCore, Inc. stock pay dividends?
No, electroCore, Inc. (ECOR) stock does not pay dividends to its shareholders as of July 03, 2025.
When is the next electroCore, Inc. dividend payment date?
electroCore, Inc. (ECOR) stock does not pay dividends to its shareholders.
What is the beta indicator for electroCore, Inc.?
electroCore, Inc. (ECOR) has a beta rating of 0.8. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.